The human X chromosome harbors only 4% of our genes but over 20% of loci associated with intellectual disability. Because they inherit only one X-chromosome, males are more frequently affected by X-linked neurodevelopmental genetic disorders. Despite inheriting two X-chromosomes, however, females can also be affected because X-chromosome inactivation (XCI) enables only one of two X chromosomes to be expressed per cell. Notable examples include Rett, CDKL5, and Fragile X syndromes. For these disorders, disease-specific treatments have remained elusive. In female subjects, a cure may be found within their own cells, as every sick cell carries a healthy copy of the affected gene on the inactive X (Xi). Selective Xi-reactivation may therefore be a viable approach that would address the root cause of various X-linked disorders. We will discuss current approaches to reactivate the silent MECP2 allele.
The European Laboratory Research & Innovation Group
Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Get the App
Get this event information on your mobile by going to the Apple or Google Store and search for 'myEventflo'